Cyclooxygenase in biology and disease

FASEB Journal

Volumn 12, Issue 12, 1998, Pages 1063-1073

  DuBois, Raymond N ^a,g   Abramson, Steven B ^b   Crofford, Leslie ^c   Gupta, Rajnish A ^a   Simon, Lee S ^d   Van De Putte, Leo B A ^e   Lipsky, Peter E ^f  

^a VANDERBILT UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Frostaglandins; Inflammation

Indexed keywords

CELOCOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; BONE METABOLISM; BRAIN FUNCTION; COLORECTAL CANCER; ENZYME INHIBITION; HUMAN; INFLAMMATION; INTRATHECAL DRUG ADMINISTRATION; KIDNEY FUNCTION; NONHUMAN; OVARY FUNCTION; PAIN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; STOMACH ULCER;

EID: 0031689543     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.12.1063     Document Type: Article

References (117)

1. Vane, J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (London) 231, 232-235
2. Mead, J. F., Alfin-Slater, R. B., Howton, D. R., and Popjak, G. (1986) Prostaglandins, thromboxanes, and prostacyclin. In Lipids: Chemistry, Biochemistry, and Nutrition (Mead, J. F., ed) pp. 149-216, Plenum Press, New York
3. Herschman, H. R. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta 1299, 125-140
4. Herschman, H. R., Xie,W., and Reddy, S. (1995) Inflammation, reproduction, cancer and all that.... The regulation and role of the inducible prostaglandin synthasc. Bioessays 17, 1031-1037
5. Simon, L. S. (1996) Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr. Opin. Rheum. 8, 169-175
6. Breyer, M. D., Jacobson, H. R., and Breyer, R. M. (1996) Functional and molecular aspects of renal prostaglandin receptors. J. Am. Soc. Nephrol 7, 8-17
7. Forman, B. M., Chen, J., and Evans, R. M. (1996) The peroxisome proliferator-activated receptors: ligands and activators, Ann. N.Y. Acad. Sci. 804, 266-275
8. Davies, N. M. (1995) Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Diseases of the Colon & Rectum 38, 1311-1321
9. Murray, M. D., and Brater, D. C. (1993) Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharm. Toxicol. 32, 435-465
10. Raz, A., Wyche, A., Siegel, N., and Needleman, P. (1988) Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Biol. Chem, 263, 3022-3028
11. Reed, D. W., Bradshaw, W. S., Xie, W., and Simmons, D. L. (1996) In vivo and in vitro expression of a non-mammalian cyclooxygenase-1. Prostaglandins 52, 269-284
12. Smith, W., Garavito, R., and DeWitt, D. (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol Chem. 271, 33157-33160
13. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. (1996) Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93, 4816-4820
14. 2 and distal prostaglandin synthasc 1. J. Biol. Chem. 271, 186-191
15. Williams, C. S., and DuBois, R. (1996) Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol 270, G393-G400
16. Hoff, T., DeWitt, D., Kaever, V., Resch, K., and Goppelt-Struebe, M. (1993) Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett. 320. 38-42
17. Murakami, M., Matsumoto, R., Austen, K. F., and Arm, J. P. (1994) Prostaglandin endoperoxide synthase-1 and-2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J. Biol. Chem, 269, 22269-22275
18. Ueda, N., Yamashita, R., Yamamoto, S., and Ishimura, K. (1997) Induction of cyclooxygenase-1 in a human megakaryoblastic cell line (CMK) differentiated by phorbol ester. Biochim. Biophys. Acta 1344, 103-110
19. Smith, C. J., Morrow, J. D., Roberts, L. J., and Marnett, L. J. (1993) Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem. Biophys. Res. Commun. 192, 787-793
20. Crofford, L. J. (1997) COX-1 and COX-2 tissue expression: implications and predictions. J. Rheum. 24, 15-19
21. Schafer, A. I. (1995) Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J. Clin. Pharmacol. 35, 209-219
22. Palmer, B. F., and Henrich, W. L. (1995) Clinical acute renal failure with nonsteroidal anti-inflammatory drugs. Semin. Nephrol 15, 214-227
23. Zambraski, E. J. (1995) The effects of nonsteroidal anti-inflammatory drugs on renal function: experimental studies in animals. Semin. Nephrol. 15, 205-213
24. Trevethick, M. A., Oakley, I., Clayton, N. M., and Strong, P. (1995) Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: underlying pathological mechanisms. Gen. Pharmacol. 26, 1455-1459
25. Wallace, J. L. (1997) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112, 1000-1016
26. Spangler, R. S. (1996) Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy. Semin. Arth. Rheum. 26, 435-436
27. DeWitt, D. L, Meade, E. A., and Smith, W. L. (1993) PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am. J. Med. 95, 40S-44S
28. Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., DuBois, R. N., and Breyer, M. D. (1994) Cyclooxygenase-2 is associated with the macula densa in rat kidney and increases with salt restriction. J. Clin. Invest. 94, 2504-2510
29. Guan, Y., Cluing, M., Cho, W., Zhang, Y., Redha, R., Davis, L., Chang, S., DuBois, R. N., Hao, C. M., and Breyer, M. (1997) Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. Am. J. Physiol. 273, F18-F26
30. Harris, R. C. (1996) The macula densa: recent developments. J. Hypertension 14, 815-822
31. Stokes, J. B. (1979) Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J. Clin. Invest. 64, 495-502
32. Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., Gorry, S. A., and Trzaskos, J. M. (1995) Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature (London) 378, 406-409
33. Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., and Smithies, O. (1995) Prostaglandin synthase-2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482
34. Cao, C., Matsumura, R.,Yamagata, K., and Watanabe, Y. (1997) Involvement of cyclooxygenase-2 in LPS-induccd fever and regulation of its mRNA by LPS in the rat brain. Am. J. Physiol. 272, R1712-R1725
35. Matsumura, K., Cao, C., and Watanabe, Y. (1997) Possible role of cyclooxygenase-2 in the brain vasculature in febrile response. Ann. N.Y. Acad. Sci. 813, 302-306
36. Taniguchi, Y., Yokoyama, K., Inui, K., Deguchi, Y., Furukawa, K., and Noda, K. (1997) Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide. Eur. J. Pharmacol. 330, 221-229
37. Cao, C., Matsumura, K., and Watanabe, Y. (1997) Induction of cyclooxygenase-2 in the brain by cytokines. Ann. N.Y. Acad. Sci. 813, 307-309
38. Bauer, M. K., Lieb, K., Schulze-Osthoff, K., Berger, M., Gebicke-Haerter, P. J., Bauer, J., and Fiebich, B. L. (1997) Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243, 726-731
39. Kaufmann, W. E., Worley, P. F., Taylor, C. V., Bremer, M., and Isakson, P. C. (1997) Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome. Brain Dev. 19, 25-34
40. Yamagata, K., Andreasson, K., Kaufmann, W., Barnes, C., and Worley, P. (1998) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11, 371-386
41. Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., and Isakson, P. (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 93, 2317-2321
42. Tocco, G., Freire-Moar, J., Schreiber, S., Sakhi, S., Aisen, P., and Pasinetti, G. (1997) Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Al-zheimer's disease. Exp. Neurol. 144, 339-349
43. Miettinen, S., Fusco, F. R., Yrjanheikki, J., Keinanen, R., Hirvonen, T., Roivainen, R., Narhi, M., Hokfelt, T., and Koistinaho, J. (1997) Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc. Natl. Acad. Sci. USA 94, 6500-6505
44. Scheiman, J. M. (1996) NSAIDs, gastrointestinal injury, and cytoprotection. Gastroenterol. Clin. N. Am. 25, 279-298
45. Roth, S. H. (1996) NSAID gastropathy. A new understanding. Arch. Int. Med. 156, 1623-1628
46. Conn, S. M., Schloemann, S., Tessner, T., Seibert, K., and Stenson, W. F. (1997) Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J. Clin. Invest. 99, 1367-137947.
47. 2α production. J. Clin. Invest. 100, 290-309
48. Simon, L. S. (1997) Biologic effects of nonsteroidal anti-inflammatory drugs. Curr. Opin. Rheum. 9, 178-182
49. Giannella, R. A., Formal, S. B., Dammin, G. J., and Collins, H. (1973) Pathogenesis of Salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reactions in the rabbit ileum. J. Clin. Invest. 52, 441-453
50. O'Brien, W. F. (1995) The role of prostaglandins in labor and delivery. Clin. Perinatol. 22, 973-984
51. Zuckerman, H., Reiss, U., and Rubinstein, I. (1974) Inhibition of human premature labor by indomethacin. Obstet. Gynecol. 44, 787-792
52. Hammerman, C. (1995) Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clin. Perinatol. 22, 457-479
53. Richards, J. S., Fitzpatrick, S. L., Clemens, J. W., Morris, J. K., Alliston, T., and Sirois, J. (1995) Ovarian cell differentiation: a cascade of multiple hormones, cellular signals, and regulated genes. Rec. Prog. Hormone Res. 50, 223-254
54. Richards, J. (1994) Hormonal control of gene expression in the ovary. Endocr. Rev. 15, 725-751
55. Tsafriri, A. (1995) Ovulation as a tissue remodelling process. Proteolysis and cumulus expansion. Adv. Exp. Med. Biol. 377, 121-140
56. Li, J., Simmons, D. L., and Tsang, B. K. (1996) Regulation of hen granulosa cell prostaglandin production by transforming growth factors during follicular development: involvement of cyclooxygenase-2. Endocrinology 137, 2522-2529
57. 2α receptor expression by interleukin-1b in cultured human granulosa-luteal cells. Endocrinology 138, 3638-3644
58. Morris, J. K., and Richards, J. S. (1996) An E-box region within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells. J. Biol. Chem. 271, 16633-16043
59. Chakraborty, I., Das, S. K., Wang, J., and Dey, S. K. (1996) Developmental expression of the cyclooxygenase-1 and cyclooxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J. Mol. Endocrinol 16, 107-122
60. Yang, Z. M., Das, S. K., Wang, J., Sugimoto, Y., Ichikawa, A., and Dey, S. K. (1997) Potential sites of prostaglandin actions in the periimplantation mouse uterus: differential expression and regulation of prostaglandin receptor genes. Biol. Reprod. 56, 368-379
61. Lim, H., and Dey, S. K. (1997) Prostaglandin E-2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology 138, 4599-4606
62. Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., and Dey, S. R. (1997) Multiple female reproductive failures in cyclooxygenase-2 deficient mice. Cell 91, 197-208
63. Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Kanaka, R., Karsuyama, M., Hasumoto, K., Murata, T., Hirata, M., Ushikubi, F., Negishi, M., Ichikawa, A., and Narumiya, S. (1997) Failure of parturition in mice lacking the prostaglandin F receptor. Science277, 681-683
64. Kawaguchi, H., Pilbeam, C. C., Harrison, J. R., and Raisz, L. G. (1995) The role of prostaglandins in the regulation of bone metabolism. Clin. Orthop. Relat. Res. 313, 36-46
65. Woodiel, F. N., Fall, P. M., and Raisz., L. G. (1996) Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure-activity relations and signal transduction pathway. J. Bone Miner. Res. 11, 1249-1255
66. Klein-Nulend, J., Burger, E. H., Semeins, C. M., Raisz, L. G., and Pilbeam, C. C. (1997) Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J. Bone Miner. Res. 12, 45-51
67. Pilbeam, C. C., Harrison, J. R., and Raisz, L. G. (1996) Prostaglandins and bone metabolism. In Principles of Bone Biology (Bilezikian, J., Raisz, L. and Rodan, G., eds.), pp. 715-728, Academic Press, New York
68. Pilbeam, C. C., Fall, P. M., Alander, C. B., and Raisz, L. G. (1997) Differential effects of nonsteroidal anti-inflammatory drugs on constituitive and inducible prostaglandin G/ H synthase in cultured bone cells. J. Bone Miner. Res. 12, 1198-1203
69. Allison, A. C., Chin, R. C., and Cheng, Y. (1993) Cyclooxygenase inhibitors vary widely in potency for preventing cytokine-induced bone resorption. Ann. N.Y. Acad. Sci. 696, 303-306
70. Jeffcoat, M. K., Reddy, M. S., Moreland, L. W., and Koopman, W. J. (1993) Effects of nonsteroidal antiinflammatory drugs on bone loss in chronic inflammatory disease. Ann. N.Y. Acad. Sci. 696, 292-302
71. Sato, T., Morita, I., Sakaguchi, K., Nakahama, K., and Murota, S. (1995) Involvement of cyclooxygenase-2 in bone loss induced by interleukin-1β. Adv. Prostaglandin, Thromboxane, Leukotriene Res. 23, 445-447
72. Tai, H., Miyaura, C., Pilbeam, C. C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz., L. G., and Suda, T. (1997) Transcriptional induction of cydooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology 138, 2372-2379
73. Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q. R., Seo, H., Ohta, H., Nozawa, S., Kudo, I., and Suda, T. (1996) IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J. Immunol. 156, 758-764
74. Tetradis, S., Pilbeam, C. C., Liu, Y., Herschman, H. R., and Kream, B. E. (1997) Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3′,5′-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells. Endocrinology 138, 3594-3600
75. Tjandrawinata, R. R., Vincent, V. L., and Hughes-Fulford, M. (1997) Vibrational force alters mRNA expression in osteoblasts. FASEB J. 11, 493-497
76. Lands, W. E. (1979) The biosynthesis and metabolism of prostaglandins. Annu. Rev. Physiol. 41, 633-652
77. Needleman, P., and Isakson, P. C. (1997) The discovery and function of COX-2. J. Rheum. 24, 6-8
78. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., and Gregory, S. A. (1996) Selective inhibition of cylooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukcn 6 in rat adjuvant arthritis. J. Clin. Invest. 97, 2672-2679
79. Amin, A. R., Attur, M., Patel, R. N., Thakker, G. D., Marshall, P. J., Rediske, J., Stuchin, S. A., Patel, I. R., and Abramson, S. B. (1997) Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide, J. Clin. Invest. 99, 1231-1237
80. Rang, R. Y., Freire-Moar, J., Sigal, E., and Chu, C. Q. (1996) Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br. J. Rheum. 35, 711-718
81. Manfield, L., Jang, D., and Murrell, G. A. (1996) Nitric oxide enhances cyclooxygenase activity in articular cartilage. Inflamm. Res. 45, 254-258
82. Penning, T., Talley, J., Bertenshaw, S., Carter, J., Collins, P., Docter, S., Graneto, M., Lee, L., Malecha, J., Miyashiro, J., Rogers, R., Rogier, D., Yu, S., Andersen, G., Burton, E., Cogburn, J., Gregory, S., Koboldt, C., Perkins, W., Seibert, K., Veenhuizen, A., Zhang, Y., and Isakson, P. (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib). J. Med. Chem. 440, 1347-1365
83. Lipsky, P. E., and Isakson, P. C. (1997) Outcome of specific COX-2 inhibition in rheumatoid arthritis. J. Rheum. 24, 9-14
84. Dray, A., and Urban, L. (1996) New pharmacological strategies for pain relief. Annu. Rev. Pharmacol. Toxicol. 36, 253-280
85. Yamamoto, T., and Nozaki-Taguchi, N. (1996) Analysis of the effects of cyclooxygenase (COX)-l and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor. Brain Res. 739, 104-110
86. Cherng, C. H., Wong, C. S., and Ho, S. T. (1996) Spinal actions of nonsteroidal anti-inflammatory drugs. Acta Anaesthesiol. Sinica 34, 81-88
87. Cashman, J. N., and McAnulty, G. (1995) Nonsteroidal antiinflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use. Drugs 49, 51-70
88. Cashman, J. N. (1996) The mechanisms of action of NSAIDs in analgesia. Drugs 52, 13-23
89. Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G., and Goppelt-Struebe, M. (1996) Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390, 165-169
90. Laird, J. M. A., Herrero, J. F., Garcia de la Rubia, P., and Cervero, F. (1997) Analgesic activity of the novel COX-2 preferring NSAID, meloxicam, in mono-arthritic rats: central and peripheral components. Inflamm. Res. 46, 203-210
91. Lane, N. E. (1997) Pain management in osteoarthritis: the role of COX-2 inhibitors. J. Rheum. 24, 20-24
92. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P. (1994) Pharmacological and biomedical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91, 12013-12017
93. Andersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M., and Hofman, A. (1995) Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 45, 1441-1445
94. McGeer, P. L., Schulzer, M., and McGeer, E. G. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425-432
95. Stewart, W. F., Kawas, C., Corrada, M., and Metter, E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632
96. Breitner, J., Welsh, K., Helms, M., Gaskell, P., Gau, B., Roses, A., Pericak-Vance, M., and Saunders, A. (1995) Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523-530
97. Breitner, J. (1996) NeurobiologInflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal, Neurobiol. Aging 11, 789-794
98. de la Torre, J. C. (1997) Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 43, 26-43
99. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Int. Med. 121, 241-246
100. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. (1995) Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333, 609-614
101. Smalley, W., and DuBois, R. N. (1997) Colorectal cancer and non steroidal anti-inflammatory drugs. Adv. Pharmacol. 39, 1-20
102. Thun, M. J., Namboodiri, M. M., and Heath, C. W. J. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325, 1593-1596
103. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W. J. (1993) Aspirin use and risk of fatal cancer. Cancer Res. 53, 1322-1327
104. Giardiello, F. M., Offerhaus, G. J. A., and DuBois, R. N. (1995) The role of nonsteroidal antiinflammatory drugs in colorectal cancer prevention. Eur. J. Cancer 31A, 1071-1076
105. Williams, C. S., Smalley, W., and DuBois, R. N. (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest. 100, 1-5
106. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58, 409-412
107. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188
108. Kargman, S., O'Neill, G., Vickers, P., Evans, J., Mancini, J., and Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55, 2556-2559
109. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Rondo, M., and Hla, T. (1995) Expression of cyclooxygenase-1 and-2 in human colorectal cancer. Cancer Res. 55, 3785-3789
110. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R., Morrow, J., Beauchamp, R. D., and DuBois, R. N. (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99, 2254-2259
111. Sheng, H., Shao, J., Morrow, J., Beauchamp, R. D., and DuBois, R. N. (1998) Modulation of apoptosis by prostaglandin treatment in human colon cancer cells. Cancer Res. 58, 362-366
112. Tsujii, M., and DuBois, R. N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83, 493-501
113. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716
114. Δ716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell 87, 803-809
115. Piazza, G. A., Rahm, A. L., Krutzsch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R., and Ahnen, D. J. (1995) Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55, 3110-3116
116. Thompson, H. J., Jiang, C., Lu, J. X., Mehta, R. G., Piazza, G. A., Paranka, N. S., Pamukcu, R., and Ahnen, D. J. (1997) Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 57, 267-271
117. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52, 237-245